Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
176
-
Total 13F shares, excl. options
-
46,800,681
-
Shares change
-
+3,928,010
-
Total reported value, excl. options
-
$2,199,661,172
-
Value change
-
+$196,122,715
-
Put/Call ratio
-
123%
-
Number of buys
-
85
-
Number of sells
-
-86
-
Price
-
$47.00
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2018
222 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q3 2018.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46,800,681 shares
of 80,437,135 outstanding shares and own 58.2% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (4,458,295 shares), BlackRock Inc. (3,639,709 shares), RTW INVESTMENTS, LP (3,275,591 shares), FMR LLC (2,765,788 shares), FRANKLIN RESOURCES INC (2,625,634 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,492,785 shares), STATE STREET CORP (2,276,178 shares), BOXER CAPITAL, LLC (2,155,000 shares), D. E. Shaw & Co., Inc. (1,756,889 shares), and SCOPIA CAPITAL MANAGEMENT LP (1,616,998 shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.